Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo

Indian Journal of Dermatology

Volumn 53, Issue 1, 2008, Pages 9-11

  Moradi, Sedighe ^a   Ghafarpoor, Gholamhossein ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Thyroid antibodies; Thyroid dysfunction; Vitiligo

Indexed keywords

CALCIUM; PHOSPHORUS; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; SCHOOL CHILD; THYROID DISEASE; THYROID FUNCTION TEST; VITILIGO;

EID: 42549127772     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.39733     Document Type: Article

References (15)

1. Lacovelli P, Sinagra JL, Vidiolin AP, Marendas, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2003;210:26-30.
2. Alkhateeb A, Fain PR, Thody A, Bennett D, Spritz RA. Epidemiology A, of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14.
3. Ongenaek, Geel NV, Naeyaen JM. Evidence for an autommune pathogenesis of vitiligo. Pigment Cell Res 2003;16:90.
4. Vanden WR, Wanknowics KA, Lepoole C. Local immune response in skin of gerenalized vitiligo patients. Lab Invest 2000;80:1299-309.
5. Yu Hs, Kao CH, Yu CL. Coexistence and relationship of antikeratinocyte and antimelanocyteantibodies in patients with non-segmental type vitiligo. J Invest Dermatol 1993;100:823-8.
6. Kurtev A, Dourmishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venerol 2004;18:109.
7. Dave S, D'souza M, Thapp DM, Reddy KS, Bobby Z. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol 2003;48:68-72.
8. Manighalam SH, Hajiabdolhamid M, Tosi P, Javanbakht A, Saadat N. Association between vitiligo and thyroid dysfunction. Int J Endocrinol Metab 2002;4:165-8.
9. Daneshpazhooh M, Mostofizadeh GM, Behjati J, Akhyani M, Mahmoud-Robati R. Anti-thyroid peroxidase antibody and vitiligo: A controlled study. BMC Dermatol 2008;6:3.
10. Biomhoff A, Kemp FH, Gawkrodger DJ, Weetman AP, Husebye ES, Aksesen HE, et al. CTLA 4 polymorphisms are concomitant autommune diseases. Pigment Cell Res 2005;18:55.
11. th ed. Lipincott Williams and Wilkins: Philadelphia; 2000. p. 487-473.
12. Vanderpump MP, Tunbridge WM. The incidence of thyroid disorders in the community: A twenty - year's follow-up the Whickham Survey. Clin Endocrinol 1995:43:55-68.
13. Kakourou T, Kanaka GC, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol 2005;53:220-3.
14. Betterle C, Caretto A, Dezio A, Pedini B, Veller-Fornasa C, Cecchetto A, et al. Incidence and significance of organe-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologia 1985;171:419-23.
15. Heydarian P, Azizi F. Thyroid dysfunction and autoantibodies 10 years after implementation of universal salt iodiation: Tehran thyroid study. Int J Endocrinol Metab 2002;4:229-41.